from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0913c/-

LFCtreatmentdescriptionclass of inhibitor

-1.160

Amikacinug/mL Amikacintranslation

-2.105

Cap5-10ug/mL Capreomycintranslation

-2.262

Rox10-50 ug/mL Roxithromycintranslation

-1.003

SM2-5 ug/mL Streptomycintranslation

0.174

Tet5-10 ug/mL Tetracyclinetranslation

0.802

Rif0.2-5ug/mL Rifampicintranscription

0.495

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.542

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.199

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.010

CPZ10-50 ug/mL Chlorpromazinerespiration

0.396

Clofazimine10-13 ug/mL Clofaziminerespiration

0.526

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.142

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.203

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.179

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.390

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.568

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.019

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.843

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.530

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.150

KCN5-20 ug/mL Potassium cyaniderespiration

1.459

NaN30.2-2 mM Sodium aziderespiration

0.665

Nigericin50 uM Nigericinrespiration

1.194

TRC10-150 ug/mL Triclosanrespiration

0.341

TRZ10-25 ug/mL Thioridazinerespiration

-0.991

Valinomycin0.5-10 uM Valinomycinrespiration

0.832

ZnSO42 mM ZnSO4respiration

-1.479

menadione6-10 ug/mL Menadionerespiration

-0.676

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.347

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.597

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.047

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.437

NRP_1Non-replicating persistence stage 1dosRassociated

-0.437

Amp0.2mg/mL AmpicillincellWall

-0.610

Cephalexin20-100 ug/mL CephalexincellWall

0.024

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.097

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.272

EMB10-20 ug/mL EthambutolcellWall

0.230

Eta12-40 ug/mL EthionamidecellWall

0.197

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.360

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.077

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.144

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.274

BZA0.12 mg/mL BenzamidearomaticAmides

0.237

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.096

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.137

H2O24 mM hydrogen peroxideDNAdamaging

-0.527

Levo10 ug/mL LevofloxacinDNAdamaging

-0.303

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.066

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.728

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.634

UVUV-irradiationDNAdamaging

-0.199

ARP41-4 ug/mL Antitubercular compound ARP4?

0.598

Antimycin12.5-50 ug/mL Antimycin A?

-0.296

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.888

PA_110-50 ug/mL Antitubercular compound PA-1?

0.468

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.340

PA8240.2-2 ug/mL PA-824?

-0.537

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.356

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.233

Verapamil50 uM Verapamil?

0.227

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.202

methoxatin10-20 ug/mL Methoxatin?